The ALS registry Swabia and this study have been supported by the German Research Council (DFG)
Food & Drug Administration (FDA) for use by people with diabetes back in 2017so the drug, which is a brand name for semaglutide, isnt exactly new
Gastrointestinal Patients People suffering from gastrointestinal issues, including ulcers and IBD, can benefit from the healing properties of this peptide
In May 2025, Novo Nordisk formed a partnership with Septerna Inc., a biotech company focused on discovering G protein-coupled receptor (GPCR) drugs, to create oral small molecule therapies for obesity and type 2 diabetes
Digestive Enzyme Inhibitors: Semaglutide vs
And then the third piece, which I think is underrated, is it gives you a tribe to belong to